TERT expression is associated with metastasis from thin primaries, exhausted CD4+ T cells in melanoma and with DNA repair across cancer entities
Kuhn, C. K.; Meister, J.; Kreft, S.; Stiller, M.; Puppel, S.-H.; Zaremba, A.; Scheffler, B.; Ullrich, V.; Schöneberg, T.; Schadendorf, D.; Horn, S.
Show abstract
Telomerase reverse transcriptase (TERT) promoter mutations occur frequently in cancer, have been associated with increased TERT expression and cell proliferation, and could potentially influence therapeutic regimens for melanoma. As the role of TERT expression in malignant melanoma and the non-canonical functions of TERT remain understudied, we aimed to extend the current knowledge on both types of TERT alterations with respect to survival, further clinical and molecular parameters. Using multivariate models, TERT alterations were not consistently associated with survival in melanoma cohorts under immune checkpoint inhibition. The presence of CD4+ T cells increased with TERT expression and correlated with the expression of exhaustion markers. While the frequency of promoter mutations did not change with Breslow thickness, TERT expression was increased in metastases arising from thinner primaries. Enrichment analyses of single-cell RNA-seq showed TERT expression is associated with genes involved in cell migration and dynamics of the extracellular matrix, supporting the role of TERT during invasion and metastasis. Co-regulated genes in several bulk tumors and single-cell RNA-seq cohorts also indicated non-canonical functions of TERT related to mitochondrial DNA stability and nuclear DNA repair in line with increased TERT expression during chromothripsis (PCAWG cohort) and under hypoxic conditions (PCAWG and SKCM cohorts). Also in glioblastoma (Klughammer and PCAWG cohorts), TERT was co-expressed with DNA repair genes. Our results thus indicate a relevance of TERT expression in melanoma metastasis, T cell dysfunction and DNA repair across cancer entities. SignificanceIn addition to the frequently occurring TERT promoter mutations, we test TERT expression with respect to clinical and molecular associates, extending the canonical role of TERT in melanoma and other cancer entities.
Matching journals
The top 9 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Transcriptional reprogramming and constitutive PD-L1 expression in melanoma are associated with dedifferentiation and activation of interferon and tumor necrosis factor signaling pathways 95%
- Functionally and metabolically divergent melanoma-associated macrophages originate from common bone-marrow precursors 94%
- Intertumoral Genetic Heterogeneity Generates Distinct Tumor Microenvironments in a Novel Murine Synchronous Melanoma Model 93%
Similar papers in this journal
- SPARC in cancer-associated fibroblasts is an independent poor prognostic factor in non-metastatic triple-negative breast cancer and exhibits pro-tumor activity 93%
- Inhibition of the Rho/MRTF pathway improves the response of BRAF-resistant melanoma to PD1/PDL1 blockade 91%
- Circulating white blood cell traits and colorectal cancer risk: A Mendelian randomization study 90%
Similar papers in this journal
- Expression of LTR and LINE1 transposable elements defines atypical teratoid/rhabdoid tumor subtypes 92%
- Distinct Tumor-TAM Interactions in IDH-Stratified Glioma Microenvironments unveiled by Single-Cell and Spatial Transcriptomics 91%
- Identification and characterization of tertiary lymphoid structures in brain metastases 91%
Similar papers in this journal
- Immunogenomic intertumor heterogeneity across primary and metastatic sites in a patient with lung adenocarcinoma 95%
- Landscape of immune-related signatures induced by targeting of different epigenetic regulators in melanoma: implications for immunotherapy 93%
- ROLE OF cfDNA AND ctDNA TO IMPROVE THE RISK STRATIFICATION AND THE DISEASE FOLLOW-UP IN PATIENTS WITH ENDOMETRIAL CANCER: TOWARDS THE CLINICAL APPLICATION 92%
Similar papers in this journal
- Driver mutations in GNAQ and GNA11 genes as potential targets for precision immunotherapy in uveal melanoma patients 93%
- MMP2 As An Independent Prognostic Stratifier In Oral Cavity Cancers 93%
- Increased Tryptophan, But Not Increased Glucose Metabolism, Predict Resistance of Pembrolizumab in Stage III/IV Melanoma 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.